20
Participants
Start Date
April 30, 2025
Primary Completion Date
April 30, 2027
Study Completion Date
April 30, 2027
Tulavi allay Nerve Cap
"The Tulavi allay Nerve Capfirst and only fully absorbable in situ forming technology designed to protect transected nerves, prevent axonal escape, and reduce the risk of neuroma formation.~https://tulavi.com/allay-nerve-cap/"
Massachusetts General Hospital, Boston
Tulavi Therapeutics, Inc
UNKNOWN
Massachusetts General Hospital
OTHER